Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a handheld scanner find brain bleeds faster on the battlefield?

NCT ID NCT07014748

Diagnosis Sponsor: InfraScan, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 02, 2026 · Last updated Sep 03, 2026 · Updated 1 time

Summary

This study tests whether a handheld, noninvasive device called the Infrascanner Model 2500 can help doctors detect brain hemorrhages faster in people with suspected traumatic brain injury from combat. The device uses near-infrared light to spot bleeding inside the skull. Researchers will compare the time from hospital admission to a CT scan diagnosis in patients who receive standard care versus those who also get scanned with the Infrascanner. The goal is to see if the device provides useful decision support that speeds up diagnosis and treatment in conflict settings.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Infrascanner Model 2500, a handheld, noninvasive brain hematoma detector
What this could lead to
If it works, this device could help medics in war zones spot brain bleeds faster, leading to quicker treatment and better outcomes for injured soldiers.
What could go wrong
This is an observational study, not a randomized trial, so results may be influenced by other factors. The device may not work as well in real combat conditions as in controlled settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

600 people

The number who actually took part.

Started

Jan 2025

Finished

Aug 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with suspected combat-related head trauma

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with suspected combat-related head trauma identified by clinical signs of TBI on admission to the clinical enrollment site * Clinical signs of TBI: * Decreased GCS score * Abnormal pupil exam * Asymmetrical motor exam * The presence of pharmacologic sedation is not exclusion criteria. Exclusion Criteria: * Evidence of extensive scalp injury that prevent proper placement of the Infrascanner device on a subject's head or prevent placement of the device in the specified locations. * Extensive scalp injury includes lacerations, avulsions, or abrasions

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Traumatic brain hemorrhage are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Brain Hemorrhage, Traumatic injury traumatic brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Traumatic brain hemorrhage

Contacts and locations

Locations

  • Dnipropetrovsk Regional Clinical Hospital named after I.I. Mechnikov of Dnipropetrovsk Regional Council

    Dnipro, Ukraine

  • Ukrainian Military

    Kyiv, Ukraine

  • University of Alabama in Birmingham

    Birmingham, Alabama, 35294, United States

  • Vinnytsia City Clinical Hospital named after M.I.Pirogov of Vinnitsya Regional Council

    Vinnytsia, Ukraine

More trials for these conditions

Other studies related to the condition(s) this trial covers.